Endo International plc: going-concern / distress — Endo signs asset sale agreement under confirmed Chapter 11 Plan

Endo International plc

On April 14, 2024, Endo entered into a Purchase and Sale Agreement with Endo Enterprise, Endo USA, and Paladin Pharma to sell substantially all assets.
The Bankruptcy Court confirmed the Chapter 11 Plan on March 22, 2024; the sale is a key step toward emergence.
Closing conditions include HSR clearance, Irish regulatory approval, and entry of a final Confirmation Order.
No purchase price disclosed in the filing; the agreement's full text is attached as Exhibit 2.1.

Key facts

Extracted from this filing and checked against the source text.

Distress & Bankruptcy SEC 8-K Item 1.03 confidence 1.0

Endo International plc entered chapter 11 in U.S. Bankruptcy Court for the Southern District of New York (petition 2022-08-16).

Proceeding: chapter 11
Court: U.S. Bankruptcy Court for the Southern District of New York
Petition: 2022-08-16

Exact text from the filing

commenced voluntary cases (the “Chapter 11 Cases”) under Chapter 11 of the United States Bankruptcy Code (the “Bankruptcy Code”) in the U.S. Bankruptcy Court for the Southern District of New York (the “Bankruptcy Court”). The Chapter 11 Cases are being jointly administered under the caption In re Endo International plc, et al., Case No. 22-22549 (JLG).

View on SEC.gov

Browse all distress & bankruptcy →

Source: SEC EDGAR

accession 0001193125-24-100879

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.